Marketing and Privacy Issues: An Analysis of the MMA and Proposed Regulations September 2, 2004 Issue Brief This paper, by Joy Pritts of the Health Policy Institute at Georgetown University, looks at issues related to drug plan marketing activities and privacy under the MMA.Issue Brief (.pdf)
Grievance and Appeals Procedures: An Analysis of the MMA and Proposed Regulations September 1, 2004 Issue Brief This paper, by Sara Rosenbaum, J.D., Director of the Center for Health Services Research and Policy at George Washington University, examines the procedures for resolving beneficiaries' grievances and appeals under the new Medicare drug benefit. It is one in a series commissioned by the Kaiser Family Foundation that analyzes issues…
The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications June 29, 2004 Issue Brief The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to MedicationsThis report describes the pharmacy benefit management tools that will be available to private plans administering the new Medicare drug benefit, including formularies, the definition of categories and classes, and cost sharing requirements. The authors conclude…
Prescription Drug Coverage for Medicare Beneficiaries: A Summary of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 November 30, 2003 Report This document, prepared by Health Policy Alternatives, Inc., provides a detailed summary of the prescription drug provisions of the Medicare legislation (P.L. 108-173) signed by the President on December 8, 2003.Report (.pdf)
Out-of-Pocket Cost-Sharing Obligations for Low-Income Medicare Beneficiaries Under the House and Senate Prescription Drug Bills September 29, 2003 Issue Brief This issue paper provides information on the out-of-pocket expenses for prescription drugs that low-income individuals would face under the Senate versus the House Medicare prescription drug benefit legislation. Issue Paper (.pdf)
Medicare/Medicaid Dual Eligibles: Fiscal and Social Responsibilities for Vulnerable Populations April 29, 1997 Report Report: Medicare/Medicaid Dual Eligibles: Fiscal And Social Responsibility For Vulnerable Populations
Medicare Part D 2010 Data Spotlights August 31, 2010 Issue Brief The Kaiser Family Foundation has issued a collection of analyses related to the Part D Medicare stand-alone drug plan options available to seniors for calendar year 2010. Each of these spotlights focuses on a key aspect of the drug plans that will be available to Medicare beneficiaries in 2010 and…
Medicaid’s Long-Term Care Users: Spending Patterns Across Institutional and Community-based Settings October 1, 2011 Issue Brief The nation’s primary payer for long-term services and supports, Medicaid finances 43 percent of all spending on long-term care services and covers a range of services and supports, including those needed by people to live independently in the community, as well as services provided in institutions. This report provides an…
Dual Eligibles: Medicaid’s Role for Low-Income Medicare Beneficiaries May 1, 2011 Fact Sheet This updated fact sheet describes the nearly 8.9 million “dual eligibles,” the low-income elderly and persons with disabilities who are enrolled in both Medicare and Medicaid, why this population needs Medicaid, what services they receive from Medicaid, and what the new health reform law may mean for them. Fact Sheet (.pdf)
Kaiser Health Poll Report Survey – Selected Findings on Seniors’ Views of the Medicare Prescription Drug Benefit January 31, 2006 Poll Finding Kaiser Health Poll Report Survey – Selected Findings on Seniors’ Views of the Medicare Prescription Drug BenefitThis February 2006 Kaiser Family Foundation tracking poll finds that 45% of seniors say they have enrolled or plan to enroll in a drug plan, 29% say they do not intend to enroll in…
